PROGRAM. THURSDAY 1 JUNE AM Registration. Chairs. version: 29 March PM Walk-in Lunch // Registration

Size: px

Start display at page:

Download "PROGRAM. THURSDAY 1 JUNE AM Registration. Chairs. version: 29 March PM Walk-in Lunch // Registration"

Alexia Garrett
5 years ago
Views:

version: 29 March 2017 THURSDAY 1 JUNE 10.00 AM Registration 12.00 PM Walk-in Lunch // Registration 1.30-4.

1 version: 29 March 2017 THURSDAY 1 JUNE AM Registration PM Walk-in Lunch // Registration PM PL_1: Opening session Chairs Dr Kamarulzaman, Dr Sohn, Dr Li and Dr Boucher PLENARY ROOM N PM Opening by the Conference Chairs Adeeba Kamarulzaman, MBBS, FRACP, University Malaya, Malaya Annette Sohn, MD, TREAT Asia, amfar, Thailand Charles Boucher, MD, PhD, Erasmus Medical Center, The Netherlands Patrick Chung-Ki Li, MBBS, FHKCP, FHKAM, FRCP, Hong Kong Sanatorium and Hospital, Hong Kong 2.00 PM KEY NOTE LECTURE: HIV/AIDS in the Asia Pacific; Where is the epidemic heading? Chris Beyrer, MD, JHU Center for AIDS Research, Baltimore, MD, USA ASIAN SPECIFIC BARRIERS TO CASCADE OF CARE 2.30 PM Perspective Program Implementer Fuije Zhang, MD, PhD, Beijing Ditan Hospital, Capital Medical University, China 3.00 PM Perspective Community Martin Choo, MMedSci, Kuala Lumpur AIDS Support Services Society (KLASS), Malaysia 3.30 PM Discussion PM Coffee break PM PA_1: Emerging ART management paradigms - Are 2 drugs enough? Chairs Mark Boyd PLENARY ROOM N PM The Gardel study Pedro Cahn, MD, PhD, Huesped Foundation, Buenos Aires, Argentina 4.50 PM The SWORD study Chien-Ching Hung, MD, PhD, National Taiwan University College of Medicine, Taipei City, Taiwan 5.10 PM Treatment-emerged Adverse Events and Health-related Quality Of Life In HIV-infected Patients After Stable Switch From Boosted Protease Inhibitors To Raltegravir: A Multicenter, Cohort Study Susan Shin-jung Lee Abstract PM Efficacy and Safety of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide (E/C/F/TAF) in Virologically Suppressed Asian Adults with Renal Impairment Sangyoun Yang Abstract PM Discussion 5.50 PM End of Parallel session PA_ PM PA_2: Opportunistic Infections Chairs Nicholas Paton BREAK-OUT ROOM N106 - N PM What s new in the management of fungal opportunistic infections Thuy Le, MD, Dphil, Oxford University Clinical Research Unit, the Hospital for Tropical Diseases, Ho Chi Min City, Vietnam 4.50 PM Identifying TB co-infection - new approaches Charoen Chuchottaworn, MD, Central Chest in Nonthaburi, Thailand

2 5.10 PM Cost effectiveness of a screening program for Cryptococcal antigenemia among antiretroviral naive HIV infected patients with CD4< 100 cell/cumm in a referral HIV care center at Mysore, South India Sri Rama Abstract PM Acute Shigellosis among HIV-infected People in 2015: An Outbreak Investigation Yi-ting Shen Abstract PM HIV care in Yangon, Myanmar; successes, challenges and implications for policy Josh Hanson Abstract PM Discussion 5.50 PM End of Parallel session PA_ PM PA_3: Point of Care testing Chairs Philip Cunningham (proposed) BREAK-OUT ROOM N206 - N PM topic to be decided Chun-Yi Lu, MD, PhD, National Taiwan University Hospital, Taiwan 4.50 PM Innovative ways to stimulate the demand HIV and HCV testing Philip Cunningham MD, The Kirby Institute, Sydney, Australia 5.10 PM The clinical utility of the urine based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: a prospective, hospital-based study Josh Hanson Abstract PM HIV prevalence in men who have sex with men in Shinjuku 2-chome gay town, Tokyo: Result from the HIV testing program using the home collection kit Misao Takano Abstract PM HIV testing as the bridge between awareness and acceptance of PrEP among MSM Tsz Ho Kwan Abstract PM Discussion 5.50 PM End of Parallel session PA_ PM Industry sponsored symposium - GILEAD PLENARY ROOM N PM Welcome Reception / Best Abstract Award FRIDAY 2 JUNE AM Industry sponsored symposium - ViiV Health Care PLENARY ROOM N AM PL_2: Challenges in Long-term HIV Care Chairs Annette Sohn PLENARY ROOM N AM Mental health and neurocognitive issues related to adolescents who have grown up with HIV Warren Ng, MD, MPH, Columbia University Medical Center, New York, USA Aging among adults in the context of HIV Reena Rajasuriar, Mpharm, PhD, University of Malaya, Kuala Lumpur, Malaysia Neurocognitive issues among aging adults Edwina Wright, MD, PhD, Burnet Institute, Melbourne, Australia Discussion

3 AM Coffee break PM PA_4: Treatment Failure & Resistance Chairs Jonathan Schapiro PLENARY ROOM N AM Does resistance still matter? Dan Kuritzkes, MD, Harvard Medical School, Boston, MA, USA AM Resistance testing for selecting second line drugs Nicholas Paton, MD, FRCP, National University of Singapore, Singapore AM Clinical Case presentation Chien-Ching Hung, MD, PhD, National Taiwan University College of Medicine, Taipei City, Taiwan PM The emergence of transmitted protease inhibitor resistance mutations in adults starting antiretroviral therapy in northern Vietnam Thao Vu Abstract PM Highly Automated Deep Sequencing-based HIV-1 Drug Resistance Monitoring System Elian Rakhmanaliev Abstract PM Discussion PM End of Parallel session PA_ PM PA_5: Hepatitis HIV Co-infection Chair Ching-Lung Lai BREAK-OUT ROOM N106 - N AM Outbreak of Hepatitis A among HIV-infected men who have sex with men in Hong Kong Chun Kwan Bonnie Wong, MBChB, FHKAM(Med), DTM&H, Special Preventive Programme, Centre for Health Protection, Department of Health, HKSARG, Hong Kong AM HIV and intestinal co-infection Ivan FN Hung, MBChB, MD, FRCP, FHKCP, FHKAM, PDipID, The University of Hong Kong, HKSARG, Hong Kong AM High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatment Rebecca Winter Abstract AM Suitability of HCV treatment in primary care settings for individuals with HIV/hepatitis C coinfection Rebecca Winter Abstract PM Treatment of patients with chronic hepatitis C genotype 3 infection with or without cirrhosis with sofosbuvir and daclatasvir therapy Omesh Goyal Abstract PM Drug Interactions between anti-hcv Antivirals Ledipasvir/Sofosbuvir and Integrase Strand Transfer Inhibitor-Based Regimens Yiwei Lu Abstract PM Discussion PM End of Parallel session PA_5

4 PM PA_6: Capacity Building: How to design clin.trials / cohort Chair David Cooper BREAK-OUT ROOM N206 - N AM Discussion PM End of Parallel session PA_ PM LUNCH Break PM PA_7: Key Populations Chairs Chris Beyrer PLENARY ROOM N PM HIV and adolescents: How do we help them to prepare for adult life Rangsima Lolekha, MD, US CDC-Thailand Collaboration, Thailand 2.30 PM Transition into adult care: Factors associated with level of preparedness among adolescents living with HIV in Cambodia Siyan Yi Abstract PM Increase new case detection of HIV among MSM and TG through PDI+ Kimhai So Abstract PM Factors associated with HIV infection among transgender women in Cambodia: Results from a national integrated biological and behavioral survey Siyan Yi Abstract PM Gender difference in compliance with self-deferral for blood donation on HIV-related risk Ka Hin Cheung Abstract PM Discussion 4.00 PM End of Parallel session PA_ PM PA_8: Comorbidities (non-aids related) Chairs Adeeba Kamarulzaman BREAK-OUT ROOM N106 - N PM Renal disease and HIV Sanjay Pujari, MD, MBBS, Institute of Infectious Diseases, Pune, India 2.25 PM Cardiovascular disease and HIV Somnuek Sunkanuparph, MPH, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand 2.50 PM Assessment of atherosclerotic cardiovascular disease (ASCVD) risks between HIV-infected patients receiving first-line and second-line antiretroviral therapy Jaruwan Tiarukkitsagul Abstract PM Higher burden of chronic comorbidities among aged hospitalized HIV patients compared to non-hiv infected patients in Japan Daniel Ruzicka Abstract PM Prevalence of sarcopenia and associated risk factors among HIV-infected individuals receiving suppressive antiretroviral therapy Siti Azdiah Abdul Aziz Abstract PM Social support plays a critical role in enhancing mental health among HIV-infected patients in Hanoi, Vietnam Matsumoto Shoko Abstract PM Discussion

5 4.00 PM End of Parallel session PA_ PM PA_9: Technology-based HIV service delivery models Chairs Margaret Hellard and Joe Tucker BREAK-OUT ROOM N206 - N PM Recruiting people into HIV Services: ebooking Panus Na Nakorn, Thai Red Cross AIDS Research Centre, Bangkok, Thailand 2.25 PM Online platforms to spur HIV testing Joe Tucker, MD, PhD, AM, UNC School of Medicine, Chapital Hill, USA 2.50 PM e-cascade for real-time monitoring of HIV program Matthew Avery, MPH, FHI360 Krung Thep Maha Nakhon, Thailand 3.15 PM Consideration regarding the service model on pre-exposure prophylaxis for men who have sex with men in the community Tsz Ho Kwan Abstract PM Pre-Exposure Prophylaxis Uptake among Men who have Sex with Men at a Clinic in Bangkok, Thailand, 2016 Wipas Wimonsate Abstract PM Using a robust incentive-based, peer-centered model to identify new HIV cases among men who have sex with men, transgender women, and people who inject drugs in Cambodia Ratana Sopha Abstract PM Discussion 4.00 PM End of Parallel session PA_ PM Coffee Break 4.30 PM PL_3: Implementation of PrEP Chairs Nittaya Phanuphak PLENARY ROOM N PM Introduction Nittaya Phanuphak, MD, PhD, Thai Red Cross AIDS Research Centre, Bangkok, Thailand Population-based PrEP implementation in NSW, Australia Andrew Grulich, MBBS, PhD, The Kirby Institute, UNSW Sydney, Sydney, Australia Round Table Discussion True demand from the communities Midnight Poonkasetwattana, MSc, Asia Pacific Coalition on Male Sexual Health, Bangkok, Thailand Genuine supply from the providers Rossana Ditangco, MD, Research Institute for Tropical Medicine, Metro Manila, Philippines PrEP research and implementation gaps Michael Cassell, PhD, MA, MEM, USAID, Bangkok, Thailand Wrap - up Nittaya Phanuphak, MD, PhD, Thai Red Cross AIDS Research Centre, Bangkok, Thailand PM Industry sponsored symposium - AbbVie PLENARY ROOM N101

6 SATURDAY 3 JUNE AM Industry sponsored symposium - Janssen PLENARY ROOM N AM PL_4: Access to Hepatitis C treatment in the region Chairs Jürgen Rockstroh PLENARY ROOM N AM Access to treatment/care on global level Margaret Hellard, MBBS, FRACP, FAFPHM,PHD, Burnet Institute, Melbourne, Australia 9.25 AM Access to treatment/care on country level Giten Khwairakpam, TREAT Asia, Bangkok, Thailand 9.50 AM Barriers to access - Community perspective Martin Choo, MMedSci, Kuala Lumpur AIDS Support Services Society (KLASS), Malaysia AM Discussion AM Coffee break AM PL_5: New drugs on the Horizon Chairs Charles Boucher & Patrick Li PLENARY ROOM N AM New HIV Drugs / Regimens Dan Kuritzkes, MD, Harvard Medical School, Boston, MA, USA AM New Hepatitis Drugs Jürgen Rockstroh, MD, University of Bonn, Bonn, Germany AM New TB Drugs Nicholas Paton, MD, FRCP, National University of Singapore, Singapore PM Discussion 1.00 PM Closure of the Conference by the Conference Chairs PLENARY ROOM N201

13:30 h Opening of the conference Conference Chairs: Mark Boyd, Patrick Chung-Ki Li and Annette Sohn

Thursday, 28 June 13:30 h Opening of the conference Conference Chairs: Mark Boyd, Patrick Chung-Ki Li and Annette Sohn 13:45 h Professor David Cooper Tribute Eulogy Praphan Phanuphak, MD, PhD Thai Red